SEC Form 4 · accession 0001144204-15-002866

ACHILLION PHARMACEUTICALS INC · ACHN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

RA Capital Healthcare Fund LP

10% Owner

RA CAPITAL MANAGEMENT, LLC

Other

Peter Kolchinsky

10% Owner

Period of report

Jul 15, 2013

Accepted (ET)

Jan 20, 2015 · 6:09 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070336

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value^F1,F6	Jul 17, 2013	P	38,400	$7.0934	A	5,365,873	D
Common Stock, $0.001 par value^F1,F6	Jul 19, 2013	S	38,400	$7.2125	D	5,327,473	D
Common Stock, $0.001 par value^F1,F6	Jul 22, 2013	P	24,883	$7.16	A	5,365,873	D
Common Stock, $0.001 par value^F1,F6	Jul 22, 2013	P	38,400	$7.2311	A	5,340,990	D
Common Stock, $0.001 par value^F1,F6	Jul 24, 2013	S	7,862	$7.2552	D	5,302,590	D
Common Stock, $0.001 par value^F1,F6	Jul 25, 2013	P	37,250	$7.1947	A	5,310,452	D
Common Stock, $0.001 par value^F1,F6	Jul 25, 2013	S	14,592	$7.15	D	5,273,202	D
Common Stock, $0.001 par value^F1,F6	Jul 25, 2013	S	40,829	$7.1948	D	5,287,794	D
Common Stock, $0.001 par value^F1,F6	Jul 29, 2013	P	11,441	$6.90	A	5,328,623	D
Common Stock, $0.001 par value^F1,F6	Jul 29, 2013	P	6,453	$6.905	A	5,317,182	D
Common Stock, $0.001 par value^F1,F6	Jul 29, 2013	S	3,377	$6.9525	D	5,310,729	D
Common Stock, $0.001 par value^F1,F6	Aug 2, 2013	P	23,100	$6.9835	A	5,314,106	D
Common Stock, $0.001 par value^F1,F6	Aug 5, 2013	S	23,100	$7.1141	D	5,291,006	D
Common Stock, $0.001 par value^F1,F6	Aug 9, 2013	P	77,000	$6.30	A	5,314,106	D
Common Stock, $0.001 par value^F1,F6	Aug 20, 2013	P	38,500	$6.7492	A	5,237,106	D
Common Stock, $0.001 par value^F1,F6	Aug 20, 2013	S	9,951	$6.8643	D	5,198,606	D
Common Stock, $0.001 par value^F1,F6	Aug 21, 2013	P	23,100	$6.6922	A	5,208,557	D
Common Stock, $0.001 par value^F1,F6	Aug 21, 2013	S	4,312	$6.8741	D	5,185,457	D
Common Stock, $0.001 par value^F1,F6	Aug 22, 2013	P	52,652	$6.7645	A	5,189,769	D
Common Stock, $0.001 par value^F1,F6	Aug 26, 2013	P	115,500	$6.575	A	5,137,117	D
Common Stock, $0.001 par value^F1,F6	Aug 26, 2013	P	38,500	$6.58	A	5,021,617	D
Common Stock, $0.001 par value^F1,F6	Aug 27, 2013	P	77,000	$6.485	A	4,983,117	D
Common Stock, $0.001 par value^F1,F6	Aug 28, 2013	P	38,500	$6.385	A	4,906,117	D
Common Stock, $0.001 par value^F1,F6	Sep 11, 2013	P	19,400	$7.18	A	4,867,617	D
Common Stock, $0.001 par value^F1,F6	Sep 11, 2013	P	19,400	$7.205	A	4,848,217	D
Common Stock, $0.001 par value^F1,F6	Sep 11, 2013	S	38,800	$7.30	D	4,828,817	D
Common Stock, $0.001 par value^F1,F6	Sep 12, 2013	P	6,906	$7.195	A	4,867,617	D
Common Stock, $0.001 par value^F1,F6	Sep 12, 2013	P	4,190	$7.205	A	4,860,711	D
Common Stock, $0.001 par value^F1,F6	Sep 12, 2013	P	7,761	$7.205	A	4,856,521	D
Common Stock, $0.001 par value^F1,F6	Sep 12, 2013	S	18,857	$7.265	D	4,848,760	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Call Option (right to buy)^F1,F6,F2,F3	$7.50	Jul 15, 2013	P	768	A	—	Jan 17, 2015	Common Stock	76,800	768	D
Call Option (obligation to sell)^F1,F6,F2,F3	$20.00	Jul 15, 2013	S	768	D	—	Jan 17, 2015	Common Stock	76,800	768	D
Call Option (right to buy)^F1,F6,F2,F4	$7.50	Jul 25, 2013	P	3,072	A	—	Jan 17, 2015	Common Stock	307,200	3,072	D
Call Option (obligation to sell)^F1,F6,F2,F4	$20.00	Jul 25, 2013	S	3,072	D	—	Jan 17, 2015	Common Stock	307,200	3,072	D
Call Option (right to buy)^F1,F6,F2,F5	$7.50	Sep 26, 2013	P	7,760	A	—	Jan 18, 2014	Common Stock	776,000	7,760	D
Call Option (obligation to sell)^F1,F6,F2,F5	$15.00	Sep 26, 2013	S	7,760	D	—	Jan 18, 2014	Common Stock	776,000	7,760	D

Explanation of responses

F1The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Column 5 of Table I and the number of options reported in Column 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the filing date of this Form 4.
F2These options are exercisable at any time prior to their expiration.
F3These options reflect an "option spread" strategy pursuant to which the Fund simultaneously (1) purchased 768 call option contracts, each representing a right to purchase 100 shares of the issuer's common stock at $7.50 per share and (2) sold 768 call option contracts, each representing an obligation to sell 100 shares of the issuer's common stock at $20.00 per share.
F4These options reflect an "option spread" strategy pursuant to which the Fund simultaneously (1) purchased 3,072 call option contracts, each representing a right to purchase 100 shares of the issuer's common stock at $7.50 per share and (2) sold 3,072 call option contracts, each representing an obligation to sell 100 shares of the issuer's common stock at $20.00 per share.
F5These options reflect an "option spread" strategy pursuant to which the Fund simultaneously (1) purchased 7,760 call option contracts, each representing a right to purchase 100 shares of the issuer's common stock at $7.50 per share and (2) sold 7,760 call option contracts, each representing an obligation to sell 100 shares of the issuer's common stock at $15.00 per share.
F6On July 15, 2013, the Fund became a beneficial owner of more than ten percent of the outstanding shares the issuer's common stock and therefore became subject to Section 16 of the Securities Exchange Act of 1934. On September 23, 2014, the Fund ceased to be a beneficial owner of more than ten percent of the outstanding shares the issuer's common stock and ceased to be subject to Section 16.